Digirad releases earnings for fourth quarter

Digirad released its fourth-quarter earnings this week, and the numbers showed that total revenues were $15.6 million, up from $14.1 million during the same time last year.

Adjusted net income for the quarter was $1.3 million, up from $0.9 million last year, and adjusted EBITDA was $2.1 million, up from $1.5 million last year.

For all of 2015, Digirad reported total revenues of $60.8 million, up 9 percent from $55.6 million in 2014. Adjusted net income for the full year was $4.5 million, up from $3.5 million in 2014.

Matt Molchan, Digirad President and CEO, said in a prepared statement he was happy with the company’s performance.

“I am very pleased with our performance this quarter and also for the full year 2015 as we close out the most profitable year in Digirad’s history,” Molchan said. “All our businesses continue to perform well, and we expect to continue this momentum into 2016.”

In the same statement, Molchan also shared his excitement over the recent acquisition of DMS Health Technologies for $36 million.

“Getting this deal closed was a tremendous effort by many individuals at both Companies, for which I am very thankful,” Molchan said. “We now are moving forward with our integration efforts, which have been ongoing since the closing and mainly involve harmonizing back office operations.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.